{"transactions":[{"id":732532,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:06:50.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":37037,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 17, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":85183,"source":{"system":"sec-edgar","filing":"0001193125-26-275823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526275823/ownership.xml","form_type":"4"}},{"id":749746,"issuer":{"id":4994,"kind":"organization","name":"Ceribell, Inc.","symbol":"CBLL"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T21:40:31.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\")."}],"balance_after":23284,"source":{"system":"sec-edgar","filing":"0001193125-26-257823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861107/000119312526257823/ownership.xml","form_type":"4"}},{"id":916139,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T16:26:26.000Z","date":"2026-02-04","kind":"sale","planned":false,"acquired":false,"shares":49000,"price":3.8794,"value":190090.6,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-041248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526041248/ownership.xml","form_type":"4"}},{"id":922144,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"other","planned":false,"acquired":false,"shares":129032,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant is immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.05,"expiration_date":"2028-01-17","underlying":"Class A Common Stock","underlying_shares":129032},"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922143,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"other","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant is immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.05,"expiration_date":"2027-07-24","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922142,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":27500,"price":4.2415,"value":116641.25,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":49000,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922141,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":27500,"price":4.246,"value":116765.0,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":76500,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922140,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-30","kind":"sale","planned":false,"acquired":false,"shares":46000,"price":4.5435,"value":209001.0,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":104000,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922139,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"sale","planned":false,"acquired":false,"shares":7739,"price":4.064,"value":31451.296,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Longitude Venture Partners II, L.P. (\"LVPII\") exercised warrants to purchase an aggregate of 629,032 shares of the Issuer's Class A common stock for $0.05 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,739 shares of the Issuer's shares of Class A common stock subject to the warrant to pay the exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":4029245,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922138,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"other","planned":false,"acquired":true,"shares":629032,"price":0.05,"value":31451.6,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Longitude Venture Partners II, L.P. (\"LVPII\") exercised warrants to purchase an aggregate of 629,032 shares of the Issuer's Class A common stock for $0.05 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,739 shares of the Issuer's shares of Class A common stock subject to the warrant to pay the exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":4036984,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":1108179,"issuer":{"id":4994,"kind":"organization","name":"Ceribell, Inc.","symbol":"CBLL"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T23:50:35.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":8828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 8,828 restricted stock units."}],"balance_after":15446,"source":{"system":"sec-edgar","filing":"0000950170-25-087602","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861107/000095017025087602/ownership.xml","form_type":"4"}},{"id":1123361,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T01:33:59.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10752,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":48146,"source":{"system":"sec-edgar","filing":"0000950170-25-081955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025081955/ownership.xml","form_type":"4"}},{"id":1385947,"issuer":{"id":4994,"kind":"organization","name":"Ceribell, Inc.","symbol":"CBLL"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2024-10-16T20:18:06.000Z","date":"2024-10-15","kind":"exercise","planned":false,"acquired":false,"shares":2140600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Longitude Venture Partners IV, L.P. (\"LVPIV\"). Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment, and dispositive power over the securities held by LVPIV. Juliet Tammenoms Bakker, a member of the issuer's board of directors, and Patrick G. Enright are managing members of LCPIV and may each be deemed to share voting, investment, and dispositive power over the securities held by LVPIV. Each of LCPIV, Ms. Tammenoms Bakker, and Mr. Enright disclaims beneficial ownership of such securities except to the extent of the respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2140600},"source":{"system":"sec-edgar","filing":"0000950170-24-115007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861107/000095017024115007/ownership.xml","form_type":"4"}},{"id":1385946,"issuer":{"id":4994,"kind":"organization","name":"Ceribell, Inc.","symbol":"CBLL"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-16T20:18:06.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":237234,"price":17,"value":4032978.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Longitude Venture Partners IV, L.P. (\"LVPIV\"). Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment, and dispositive power over the securities held by LVPIV. Juliet Tammenoms Bakker, a member of the issuer's board of directors, and Patrick G. Enright are managing members of LCPIV and may each be deemed to share voting, investment, and dispositive power over the securities held by LVPIV. Each of LCPIV, Ms. Tammenoms Bakker, and Mr. Enright disclaims beneficial ownership of such securities except to the extent of the respective pecuniary interests therein."}],"balance_after":2475110,"source":{"system":"sec-edgar","filing":"0000950170-24-115007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861107/000095017024115007/ownership.xml","form_type":"4"}},{"id":1385945,"issuer":{"id":4994,"kind":"organization","name":"Ceribell, Inc.","symbol":"CBLL"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-16T20:18:06.000Z","date":"2024-10-15","kind":"exercise","planned":false,"acquired":true,"shares":2140600,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Longitude Venture Partners IV, L.P. (\"LVPIV\"). Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment, and dispositive power over the securities held by LVPIV. Juliet Tammenoms Bakker, a member of the issuer's board of directors, and Patrick G. Enright are managing members of LCPIV and may each be deemed to share voting, investment, and dispositive power over the securities held by LVPIV. Each of LCPIV, Ms. Tammenoms Bakker, and Mr. Enright disclaims beneficial ownership of such securities except to the extent of the respective pecuniary interests therein."}],"balance_after":2237876,"source":{"system":"sec-edgar","filing":"0000950170-24-115007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861107/000095017024115007/ownership.xml","form_type":"4"}},{"id":1385944,"issuer":{"id":4994,"kind":"organization","name":"Ceribell, Inc.","symbol":"CBLL"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-16T20:18:06.000Z","date":"2024-10-11","kind":"grant","planned":false,"acquired":true,"shares":6618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 6,618 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents 6,618 restricted stock units."}],"balance_after":6618,"source":{"system":"sec-edgar","filing":"0000950170-24-115007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861107/000095017024115007/ownership.xml","form_type":"4"}},{"id":1485366,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:07:55.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":2554,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":37394,"source":{"system":"sec-edgar","filing":"0000950170-24-071288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024071288/ownership.xml","form_type":"4"}},{"id":1507518,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:11:17.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":61.0913,"value":305456.5,"ownership":{"direct":true},"balance_after":34840,"source":{"system":"sec-edgar","filing":"0000950170-24-062883","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024062883/ownership.xml","form_type":"4"}},{"id":1641447,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T21:15:46.000Z","date":"2024-02-14","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":51.2883,"value":205153.2,"ownership":{"direct":true},"balance_after":29840,"source":{"system":"sec-edgar","filing":"0000950170-24-015900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024015900/ownership.xml","form_type":"4"}},{"id":1641446,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T21:15:46.000Z","date":"2024-02-12","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":50.3799,"value":201519.6,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to inadvertent administrative error."}],"balance_after":25840,"source":{"system":"sec-edgar","filing":"0000950170-24-015900","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024015900/ownership.xml","form_type":"4"}},{"id":1727049,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T00:32:26.000Z","date":"2023-11-30","kind":"other","planned":false,"acquired":true,"shares":1617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members."}],"balance_after":21840,"source":{"system":"sec-edgar","filing":"0000950170-23-067110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023067110/ownership.xml","form_type":"4"}},{"id":1727048,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T00:32:26.000Z","date":"2023-11-30","kind":"other","planned":false,"acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1548,"source":{"system":"sec-edgar","filing":"0000950170-23-067110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023067110/ownership.xml","form_type":"4"}},{"id":1727047,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T00:32:26.000Z","date":"2023-11-30","kind":"other","planned":false,"acquired":false,"shares":445400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Prime Fund, L.P. (\"LPF\") to its limited partners and Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held directly by LPF. LPP, the general partner of LPF, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Mr. Enright are the managing members of LPP and may be deemed to share voting, investment and dispositive power over such securities. Each of LPF, LPP, Mr. Enright and the Reporting Person disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-23-067110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023067110/ownership.xml","form_type":"4"}},{"id":1727046,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T00:32:26.000Z","date":"2023-11-29","kind":"sale","planned":false,"acquired":false,"shares":349245,"price":29.7747,"value":10398665.1015,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.45 to $30.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over such securities. Each of LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-23-067110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023067110/ownership.xml","form_type":"4"}},{"id":1727045,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T00:32:26.000Z","date":"2023-11-28","kind":"sale","planned":false,"acquired":false,"shares":145068,"price":29.6208,"value":4297030.2144,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.37 to $30.1356, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 1 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over such securities. Each of LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":349245,"source":{"system":"sec-edgar","filing":"0000950170-23-067110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023067110/ownership.xml","form_type":"4"}},{"id":1739495,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T00:31:45.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":400000,"price":27.1954,"value":10878160.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.935 to $27.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over such securities. Each of LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":494313,"source":{"system":"sec-edgar","filing":"0000950170-23-064616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023064616/ownership.xml","form_type":"4"}},{"id":1739494,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T00:31:45.000Z","date":"2023-11-14","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":27.1259,"value":2712590.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.79 to $27.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 1 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over such securities. Each of LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":894313,"source":{"system":"sec-edgar","filing":"0000950170-23-064616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023064616/ownership.xml","form_type":"4"}},{"id":1745655,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B convertible preferred stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":2906148,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":319126},"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745654,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A convertible preferred stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":18999999,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1793429},"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745653,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"purchase","planned":false,"acquired":true,"shares":454545,"price":11,"value":4999995.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2567100,"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745652,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":319126,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2112555,"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745651,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":1793429,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1793429,"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1784061,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T22:15:23.000Z","date":"2023-09-11","kind":"sale","planned":false,"acquired":false,"shares":2950,"price":30.0084,"value":88524.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 3 to this Form 4."}],"balance_after":20223,"source":{"system":"sec-edgar","filing":"0000950170-23-047537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023047537/ownership.xml","form_type":"4"}},{"id":1784060,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T22:15:23.000Z","date":"2023-09-08","kind":"sale","planned":false,"acquired":false,"shares":10033,"price":30.2463,"value":303461.1279,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":23173,"source":{"system":"sec-edgar","filing":"0000950170-23-047537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023047537/ownership.xml","form_type":"4"}},{"id":1784059,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T22:15:23.000Z","date":"2023-09-07","kind":"sale","planned":false,"acquired":false,"shares":19967,"price":30.0988,"value":600982.7396,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.81 to $30.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 1 to this Form 4."}],"balance_after":33206,"source":{"system":"sec-edgar","filing":"0000950170-23-047537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023047537/ownership.xml","form_type":"4"}},{"id":1795492,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T23:44:19.000Z","date":"2023-08-25","kind":"sale","planned":false,"acquired":false,"shares":16208,"price":29.2528,"value":474129.3824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.23 to $29.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 5 to this Form 4."}],"balance_after":53173,"source":{"system":"sec-edgar","filing":"0000950170-23-044850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023044850/ownership.xml","form_type":"4"}},{"id":1795491,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T23:44:19.000Z","date":"2023-08-24","kind":"other","planned":false,"acquired":true,"shares":416,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":855,"source":{"system":"sec-edgar","filing":"0000950170-23-044850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023044850/ownership.xml","form_type":"4"}},{"id":1795490,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T23:44:19.000Z","date":"2023-08-24","kind":"other","planned":false,"acquired":true,"shares":970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members."}],"balance_after":69381,"source":{"system":"sec-edgar","filing":"0000950170-23-044850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023044850/ownership.xml","form_type":"4"}},{"id":1795489,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T23:44:19.000Z","date":"2023-08-24","kind":"other","planned":false,"acquired":false,"shares":267300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Prime Fund, L.P. (\"LPF\") to its limited partners and Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LPF. LPP, the general partner of LPF, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LPP and may be deemed to share voting, investment and dispositive power over such securities. Each of LPF, LPP, Mr. Enright and the Reporting Person disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":445400,"source":{"system":"sec-edgar","filing":"0000950170-23-044850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023044850/ownership.xml","form_type":"4"}},{"id":1802193,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T20:08:07.000Z","date":"2023-08-18","kind":"sale","planned":false,"acquired":false,"shares":14651,"price":29.0681,"value":425876.7331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":68411,"source":{"system":"sec-edgar","filing":"0000950170-23-043465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023043465/ownership.xml","form_type":"4"}},{"id":1802192,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T20:08:07.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":18484,"price":30.0635,"value":555693.734,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.01 to $30.2921, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 1 to this Form 4."}],"balance_after":83062,"source":{"system":"sec-edgar","filing":"0000950170-23-043465","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023043465/ownership.xml","form_type":"4"}},{"id":1810148,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T20:13:55.000Z","date":"2023-08-09","kind":"other","planned":false,"acquired":true,"shares":32950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LVP II to its members."}],"balance_after":101546,"source":{"system":"sec-edgar","filing":"0000950170-23-041859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023041859/ownership.xml","form_type":"4"}},{"id":1810147,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T20:13:55.000Z","date":"2023-08-09","kind":"other","planned":false,"acquired":false,"shares":497150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners II, L.P. (\"LVP II\") to its limited partners and Longitude Capital Partners II, LLC (\"LCP II\"), the general partner of LVP II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by LVP II. LCP II is the general partner of LVP II and may be deemed to have voting, investment and dispositive power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over the securities held by LVP II. LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":994313,"source":{"system":"sec-edgar","filing":"0000950170-23-041859","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023041859/ownership.xml","form_type":"4"}},{"id":1852906,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:49:08.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":true,"shares":439,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":439,"source":{"system":"sec-edgar","filing":"0000899243-23-015783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924323015783/doc4.xml","form_type":"4"}},{"id":1852905,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:49:08.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":true,"shares":1022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members."}],"balance_after":68596,"source":{"system":"sec-edgar","filing":"0000899243-23-015783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924323015783/doc4.xml","form_type":"4"}},{"id":1852904,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:49:08.000Z","date":"2023-06-14","kind":"other","planned":false,"acquired":false,"shares":267300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Prime Fund, L.P. (\"LPF\") to its limited partners and Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LPF. LPP, the general partner of LPF, may be deemed to have voting, investment and dispositive power with respect to such securities. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LPP and may be deemed to share voting, investment and dispositive power over such securities. Each of LPF, LPP and the Reporting Person disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":712700,"source":{"system":"sec-edgar","filing":"0000899243-23-015783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924323015783/doc4.xml","form_type":"4"}},{"id":1867706,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:36:06.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":67574,"source":{"system":"sec-edgar","filing":"0001209191-23-034338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123034338/doc4.xml","form_type":"4"}},{"id":1873588,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T22:09:40.000Z","date":"2023-05-26","kind":"other","planned":false,"acquired":true,"shares":33135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Longitude Venture Partners II, L.P. (\"LVP II\") on a pro rata basis based upon each such member's respective capital interests in LVP II. Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II."}],"balance_after":61843,"source":{"system":"sec-edgar","filing":"0001209191-23-033181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123033181/doc4.xml","form_type":"4"}},{"id":1873587,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T22:09:40.000Z","date":"2023-05-26","kind":"other","planned":false,"acquired":false,"shares":497150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Longitude Venture Partners II, L.P. (\"LVP II\") on a pro rata basis based upon each such member's respective capital interests in LVP II. Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":1491463,"source":{"system":"sec-edgar","filing":"0001209191-23-033181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123033181/doc4.xml","form_type":"4"}},{"id":2020364,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T23:20:29.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":480000,"price":12.5,"value":6000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LPP and may be deemed to share voting and investment power over the securities held by LPF. LPF, LPP and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":980000,"source":{"system":"sec-edgar","filing":"0001209191-23-008849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123008849/doc4.xml","form_type":"4"}},{"id":2026672,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":2,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":3,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":4,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-08T19:40:20.000Z","date":"2023-02-06","kind":"purchase","acquired":true,"shares":1714285,"price":7,"value":11999995.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1714285,"source":{"system":"sec-edgar","filing":"0000899243-23-004349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924323004349/doc4.xml","form_type":"4"}},{"id":2245573,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-04T00:24:35.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":10349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant.  \"Date of Grant\" shall mean June 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":28708,"source":{"system":"sec-edgar","filing":"0001209191-22-034396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122034396/doc4.xml","form_type":"4"}},{"id":2288017,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held directly by Patrick G. Enright."}],"balance_after":8015,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288016,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held by a trust. Juliet Tammenoms Bakker is the Investment Trustee of such trust and may be deemed to share voting and dispositive power with regard to the reported shares. Ms. Tammenoms Bakker disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein."}],"balance_after":2404,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288015,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":588,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held directly by Juliet Tammenoms Bakker."}],"balance_after":5611,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288014,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":7175,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held directly by Patrick G. Enright."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288013,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held by a trust. Juliet Tammenoms Bakker is the Investment Trustee of such trust and may be deemed to share voting and dispositive power with regard to the reported shares. Ms. Tammenoms Bakker disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein."}],"balance_after":2152,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288012,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":5023,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held directly by Juliet Tammenoms Bakker."}],"balance_after":5023,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288011,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":false,"shares":1964771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners III, L.P. (\"LVP III\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held directly by LVP III. Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP III and may be deemed to share voting, investment and dispositive power over such securities. Each of LCP III, Mr. Enright, and Ms. Tammenoms Bakker disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288010,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Prime Fund, L.P. (\"LPF\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LPF. Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting, investment and dispositive power over such securities. Each of LPP, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2292811,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-21T18:04:37.000Z","date":"2022-04-19","kind":"purchase","acquired":true,"shares":1355000,"price":3.69,"value":4999950.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and dispositive power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and dispositive power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":4174379,"source":{"system":"sec-edgar","filing":"0000899243-22-015325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924322015325/doc4.xml","form_type":"4"}},{"id":2304209,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-04-05T11:24:14.000Z","date":"2022-02-10","kind":"purchase","acquired":true,"shares":333333,"price":15,"value":4999995.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Mr. Enright, a managing member of LCP IV, currently serves on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer."}],"balance_after":3429927,"source":{"system":"sec-edgar","filing":"0000899243-22-013598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924322013598/doc4.xml","form_type":"4"}},{"id":2417048,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-02T21:25:50.000Z","date":"2022-02-02","kind":"purchase","acquired":true,"shares":175000,"price":27,"value":4725000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Patrick G. Enright, Juliet Tammenoms Bakker and Joshua Richardson, a member of the Issuer's board of directors, are each members of LPF and may be deemed to share voting, investment and dispositive power over such securities. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP. Each of Mr. Enright, Ms. Tammenoms Bakker and Dr. Richardson disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":175000,"source":{"system":"sec-edgar","filing":"0000899243-22-004271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322004271/doc4.xml","form_type":"4"}},{"id":2424223,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Warrants","published_at":"2022-01-27T21:23:35.000Z","date":"2022-01-25","kind":"other","acquired":false,"shares":1477125,"price":13.2,"value":19498050.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 1,477,125 Series B Warrants held by LVP III which are exercisable for an aggregate of 487,451 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker and Joshua Richardson, a member of the Issuer's board of directors, are each members of LCP III and may be deemed to share voting, investment and dispositive power over such securities. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LCP III. Each of LCP III, Mr. Enright, Ms. Tammenoms Bakker and Joshua Richardson disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":13.2,"exercise_date":"2020-01-22","expiration_date":"2022-04-10","underlying":"Common Stock","underlying_shares":487451},"source":{"system":"sec-edgar","filing":"0000899243-22-003502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924322003502/doc4.xml","form_type":"4"}},{"id":2424222,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-27T21:23:35.000Z","date":"2022-01-25","kind":"other","acquired":true,"shares":487451,"price":13.2,"value":6434353.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker and Joshua Richardson, a member of the Issuer's board of directors, are each members of LCP III and may be deemed to share voting, investment and dispositive power over such securities. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LCP III. Each of LCP III, Mr. Enright, Ms. Tammenoms Bakker and Joshua Richardson disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1964771,"source":{"system":"sec-edgar","filing":"0000899243-22-003502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924322003502/doc4.xml","form_type":"4"}},{"id":2613337,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series H Preferred Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":8177,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8177},"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613336,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series H Preferred Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"tax_withholding","acquired":false,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The warrant was automatically net exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":8177,"derivative":{"underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613335,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series H Preferred Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":36302,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The warrant was automatically net exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":36302,"derivative":{"underlying":"Common Stock","underlying_shares":36302},"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613334,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":36302,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The warrant was automatically net exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The warrant was automatically net exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"exercise_price":12.4,"exercise_date":"2017-02-24","underlying":"Series H Preferred Stock","underlying_shares":36302},"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613333,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series H Preferred Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":242013,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":242013},"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613332,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series G Preferred Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":1613423,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1613423},"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613331,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":500000,"price":16,"value":8000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LPP and may be deemed to share voting and investment power over the securities held by LPF. LPF, LPP and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613330,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":125000,"price":16,"value":2000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":1988613,"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613329,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":1863613,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrant are held by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC (\"LCP II\") is the general partner of LVP II and may be deemed to have voting and investment power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, is a managing member of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. LVP II, LCP II and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":1863613,"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2613328,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:41:39.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":12500,"price":16,"value":200000.0,"ownership":{"direct":true},"balance_after":18359,"source":{"system":"sec-edgar","filing":"0000899243-21-031826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031826/doc4.xml","form_type":"4"}},{"id":2620298,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T00:17:49.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":5859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock"},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the date immediately prior to the first annual meeting of stockholders following July 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock"}],"balance_after":5859,"source":{"system":"sec-edgar","filing":"0000899243-21-031109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031109/doc4.xml","form_type":"4"}},{"id":2629387,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":129032,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":129032,"derivative":{"exercise_price":0.05,"expiration_date":"2028-01-17","underlying":"Class A Common Stock","underlying_shares":129032},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629386,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":645160,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2028-01-17","underlying":"Series B1 Preferred Stock","underlying_shares":645160},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629385,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":500000,"derivative":{"exercise_price":0.05,"expiration_date":"2027-07-24","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629384,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2027-07-24","underlying":"Series A1 Preferred Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629383,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C1 Preferred Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2291665,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":458333},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629382,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Preferred Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":5654529,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1130904},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629381,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Preferred Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":8774007,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1754801},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629380,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"purchase","acquired":true,"shares":150000,"price":20,"value":3000000.0,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting, investment and dispositive power over the shares held by LPF.  LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629379,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":3344038,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":3407952,"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2705315,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T20:58:51.000Z","date":"2021-05-17","kind":"other","acquired":true,"shares":3508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP4 to its members"}],"balance_after":7016,"source":{"system":"sec-edgar","filing":"0000899243-21-019943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924321019943/doc4.xml","form_type":"4"}},{"id":2705314,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T20:58:51.000Z","date":"2021-05-17","kind":"other","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP4 to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by a trust. The Reporting Person is the Investment Trustee of such trust and may be deemed to share voting and dispositive power with regard to the reported shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein."}],"balance_after":3008,"source":{"system":"sec-edgar","filing":"0000899243-21-019943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924321019943/doc4.xml","form_type":"4"}},{"id":2705313,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T20:58:51.000Z","date":"2021-05-17","kind":"other","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners IV, L.P. (\"LVP4\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by LVP4. Longitude Capital Partners IV, LLC (\"LCP4\") is the general partner of LVP4 and may be deemed to have voting, investment and dispositive power over the shares held by LVP4. The Reporting Person and Patrick G. Enright are managing members of LCP4 (each a \"Manager\" and collectively, the \"Managers\") and may each be deemed to share voting, investment and dispositive power with respect to the shares held by LVP4. Each of LCP4 and the Managers disclaims beneficial ownership of the shares held by LVP4 and this report shall not be deemed an admission that any of them is the beneficial owner of such shares for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1918691,"source":{"system":"sec-edgar","filing":"0000899243-21-019943","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924321019943/doc4.xml","form_type":"4"}},{"id":2707730,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-05-19T00:20:20.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":2187504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Mr. Enright, a managing member of LCP IV, currently serves on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2187504},"source":{"system":"sec-edgar","filing":"0001209191-21-033816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919121033816/doc4.xml","form_type":"4"}},{"id":2707729,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T00:20:20.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":909090,"price":11,"value":9999990.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Mr. Enright, a managing member of LCP IV, currently serves on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer."}],"balance_after":3096594,"source":{"system":"sec-edgar","filing":"0001209191-21-033816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919121033816/doc4.xml","form_type":"4"}},{"id":2707728,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T00:20:20.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":2187504,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Mr. Enright, a managing member of LCP IV, currently serves on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer."}],"balance_after":2187504,"source":{"system":"sec-edgar","filing":"0001209191-21-033816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919121033816/doc4.xml","form_type":"4"}},{"id":2718657,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":406338,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":406338},"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718656,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":1271027,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1271027},"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718655,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":1308410,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1308410},"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718654,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":235000,"price":17,"value":3995000.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 11, 2021, LVP III purchased 235,000 shares of Common Stock of the Issuer at a price of $17.00 per share pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3220775,"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718653,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":2985775,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2985775,"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2748519,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T01:04:18.000Z","date":"2021-04-14","kind":"other","acquired":true,"shares":3508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP4 to its members."}],"balance_after":3508,"source":{"system":"sec-edgar","filing":"0000899243-21-016026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924321016026/doc4.xml","form_type":"4"}},{"id":2748518,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T01:04:18.000Z","date":"2021-04-14","kind":"other","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP4 to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by a trust. The Reporting Person is the Investment Trustee of such trust and may be deemed to share voting and dispositive power with regard to the reported shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0000899243-21-016026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924321016026/doc4.xml","form_type":"4"}},{"id":2748517,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":1,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T01:04:18.000Z","date":"2021-04-14","kind":"other","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners IV, L.P. (\"LVP4\") to its general and limited partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by LVP4. Longitude Capital Partners IV, LLC (\"LCP4\") is the general partner of LVP4 and may be deemed to have voting, investment and dispositive power over the shares held by LVP4. The Reporting Person and Patrick G. Enright are managing members of LCP4 (each a \"Manager\" and collectively, the \"Managers\") and may each be deemed to share voting, investment and dispositive power with respect to the shares held by LVP4. Each of LCP4 and the Managers disclaims beneficial ownership of the shares held by LVP4 and this report shall not be deemed an admission that any of them is the beneficial owner of such shares for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2918691,"source":{"system":"sec-edgar","filing":"0000899243-21-016026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000089924321016026/doc4.xml","form_type":"4"}},{"id":2975277,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-18T19:11:39.000Z","date":"2020-11-16","kind":"other","acquired":true,"shares":891,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Capital III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held directly by Ms. Bakker."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0000899243-20-031489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924320031489/doc4.xml","form_type":"4"}}],"next_cursor":"2020-11-18T19:11:39.000000Z,2975277"}